Healthcare Provider Engagement with a Novel Dashboard for Tracking Medication Ingestion: Impact on Treatment Decisions and Clinical Assessments for Adults with Schizophrenia

PURPOSE: Schizophrenia is a severe, chronic condition accounting for disproportionate healthcare utilization. Antipsychotics can reduce relapse rates, but the characteristics of schizophrenia may hinder medication adherence. A phase 3b open-label clinical trial used aripiprazole tablets with sensor...

Descripción completa

Detalles Bibliográficos
Autores principales: Cochran, Jeffrey M, Fang, Hui, Sonnenberg, John G, Cohen, Elan A, Lindenmayer, Jean-Pierre, Reuteman-Fowler, J Corey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9343256/
https://www.ncbi.nlm.nih.gov/pubmed/35928793
http://dx.doi.org/10.2147/NDT.S369123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9343256/
https://www.ncbi.nlm.nih.gov/pubmed/35928793
http://dx.doi.org/10.2147/NDT.S369123

Ejemplares similares